Nutrisystem to revamp plans for weight loss
Nutrisystem is jumping into the new year by announcing new diet plans for consumers and a new multi-brand strategy for the 2018 diet season ahead.
“As America strives to lose weight and become healthier, we’re committed to helping through a platform of solutions across multiple brands,” Dawn Zier, president and CEO of Nutrisystem said. “The market is growing and consumers are demanding more customized solutions that are ordered online and delivered directly to their home. This is something we’ve refined over decades, and it is a clear strength of Nutrisystem.”
Part of these launches will include the Nutrisystem Turbo 13 which includes Turbo TakeOff, a one week-jumpstart with specially designed foods. The Nutrisystem Turbo for Men program will include new NutriPro shakes and increased snacking options. The South Beach Diet also will launch a one-week phase one jumpstart called the 7-Day Body Reboot.
“Our multiple programs appeal to men and women across America who want to lose weight to improve their health and have more energy,” Keira Krausz, CMO of Nutrisystem, said. “We are committed to delivering the most convenient, easiest-to-follow weight-loss solutions. Customers can choose from hundreds of food items that nourish and satisfy, and we believe we offer the best value for the money.”
The company also announced that it will be working with musician and reality star, Jesse James Decker on a 260 marketing campaign that will launch on television, print, digital and other platforms.
Walgreens Boots Alliance reduces stake in China’s pharmacy wholesaler
It has been announced that Walgreens Boots Alliance will be reducing its stake in Guangzhou Pharmaceuticals Corporation, a pharmaceutical wholesaling joint venture in China. This announcement comes after the Deerfield, Ill.-based company announced plans earlier this year their plans to take a 40% stake in Sinopharm Holding GuoDa Drugstores.
The company will sell a 30% interest in Guangzhou Pharmaceuticals Corporation to Guangzhou Baiyunshan Pharmaceutical Holdings. This will lead Walgreens Boots Alliance to own a 20% interest in Guangzhou Pharmaceuticals Corporation, and it will allow the company to continue to account for the other’s remaining stake as an equity method investment.
This proposed deal is subject to regulatory review, approval and other customary closing conditions.
Walgreens Boots Alliance's portfolio of retail and business brands includes Walgreens, Duane Reade, Boots and Alliance Healthcare among others.
Bed, Bath & Beyond shares dip despite beating street
When do good financial results turn bad?
Just ask officials at Bed, Bath & Beyond. The beleaguered home furnishings retailer, which also owns Harmon, posted earnings that beat estimates on Thursday. The result? A $3 drop in its stock price to around $21 a share. The company’s shares were in the low $80 range as recently as two years ago.
Edison, N.J.-based Bed, Bath & Beyond posted earnings of 44 cents per share, beating consensus estimates by about 8 cents. Revenues for the quarter were $3 billion, slightly ahead of sales in the same quarter in 2016. Comparable store sales increased by ahead by about 0.3%.
Industry observers say that the company has been particularly hard hit by Amazon.com and has implemented a number of costly promotional programs to regain market share and sales. While sales rose slightly in the quarter, many believe it is at the expense of profits, thus dropping the value of the company and its stock price.
“They are doing the right things,” said one industry observer. “The problem is that it costs a lot of money to compete with Amazon and the other digital retailers. That impacts the bottom line and that is what we are seeing here. Expect more of this before things flatten out.”